Trial By Error: And Cochrane Makes Another Move…
By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On…
By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On…
By David Tuller, DrPH I spent the last week of November in Oslo. The Norwegian ME Association invited me to give a couple of talks and have some meetings with…
By David Tuller, DrPH In an eagerly awaited draft report, an Australian advisory committee on ME/CFS has called for the development of up-to-date domestic clinical guidelines and an increase in…
By David Tuller, DrPH Earlier this month, NIH director Francis Collins and other agency officials held a meeting with five representatives from #MEAction. According to the group’s post about the…
…It’s short of my goal of one post a week, but still respectable and ‘regular’. Joining me this year was virologist Gertrud U. Rey, who authored 8 posts. David Tuller…
By David Tuller, DrPH I was surprised recently when the UK press made a big splash about what was, in the end, a modest study from a team led by…